Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. STRESAM
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

STRESAM

Medicine - Posted on Jun 18 2020 - Updated on Jun 18 2020
Active substance (DCI)
  • chlorhydrate d'étifoxine
history (4)
  • 6/3/20

    STRESAM

    Reevaluation. Unfavourable opinion for maintenance of reimbursement in the psychosomatic manifestations of anxiety. Clinical...
    CAV :
    54321
    icône flèche
  • 4/5/17

    STRESAM (chlorhydrate d'étifoxine)

    Maintien du remboursement dans les mêmes conditions dans l’attente des résultats de l’étude d’efficacité demandée par l’ANSM...
    icône flèche
  • 12/14/11

    STRESAM (chlorhydrate d'étifoxine)

    STRESAM (chlorhydrate d'étifoxine)
    icône flèche
  • 1/17/07

    STRESAM (chlorhydrate d'étifoxine)

    STRESAM (chlorhydrate d'étifoxine)
    icône flèche
Technical information
ATC code
  • N05BX03
Manufacturer
BIOCODEX
Presentation

STRESAM 50 mg, gélule (code CIS : 63136857)
plaquette(s) thermoformée(s) PVC-aluminium de 60 gélule(s) (CIP: 34009 322 857 7 8)

All our publications
    Anxiety and neurotic disorders Drug therapy

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
GwV8pTMcT66xmThk